Nasus Pharma NSRX
NYSE NSRX
$3.61 +0.02 (+0.42%)
As of: Sep 29, 2026 · 3:59 PM EDT

Nasus Pharma (NSRX) Total Debt (2024 - 2025)

Updated

Nasus Pharma (NSRX) posted Total Debt of $2.56 million for Q2 2025.

Analysis

Nasus Pharma (NSRX) Total Debt (2024 - 2025) Analysis & Trends

At the end of FY2024, Nasus Pharma's Total Debt came in at $1.8 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 49.04 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 70.82 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 53.91 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 37.49 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -111.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 57.30 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 26.25 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 63.19 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Nasus Pharma 32.00 Mn 32.00 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 2.56 Mn
Dec 31, 2024 1.80 Mn
API Access

Nasus Pharma Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=NSRX&period=max&api_key=YOUR_API_KEY